Altimmune, Inc. (ALT) Tops Q3 EPS by 1c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.48), $0.01 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $2 thousand versus the consensus estimate of $867.83 thousand.

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
• Aptera Motors (SEV) Reports Q2 Loss of $0.20